News & Updates
Filter by Specialty:
Extraction-free diagnostic platforms a faster, cheaper way to detect SARS-CoV-2
Diagnostic platforms that omit the conventional nucleic acid extraction step in the detection of SARS-CoV-2 in nasopharyngeal swab samples help reduce the turnaround time and the overall testing costs, as reported in a study.
Extraction-free diagnostic platforms a faster, cheaper way to detect SARS-CoV-2
01 Oct 2021
Lung ultrasound boosts accuracy of pneumonia diagnosis in ED
Lung ultrasound proves to be a useful tool for screening community-acquired pneumonia in the emergency department (ED), with a recent study showing that its use brings down diagnostic uncertainty from 73 percent to 14 percent.
Lung ultrasound boosts accuracy of pneumonia diagnosis in ED
30 Sep 2021
Casirivimab-imdevimab combo may reduce hospitalization in mild-to-moderate COVID-19
Treatment with a combination of the recombinant human IgG1 monoclonal antibodies casirivimab and imdevimab reduced hospitalization rates in high-risk patients with mild-to-moderate COVID-19, according to results of a retrospective study.
Casirivimab-imdevimab combo may reduce hospitalization in mild-to-moderate COVID-19
29 Sep 2021
High-flowrate air samplers allow thorough monitoring for airborne SARS-CoV-2
High-flowrate air samplers are able to detect airborne SARS-CoV-2 in hospitals, outperforming even surface sampling, according to a recent Singapore study. Factors such as the site of deployment and distance of the air samplers from patients affect the viral load detected.
High-flowrate air samplers allow thorough monitoring for airborne SARS-CoV-2
28 Sep 2021
Lung function not affected in children, adolescents post-COVID
COVID-19 does not appear to result in long-term impairment of lung function in children and adolescents, according to two studies presented at ERS 2021.
Lung function not affected in children, adolescents post-COVID
27 Sep 2021
SARS-CoV-2 lurks in small airborne particles
Investigations into the role of small aerosol particles in COVID-19 transmission suggest that SARS-CoV-2 may be an airborne hazard. A recent medRxiv preprint study from Singapore adds to this body of evidence.